Jeremy D. Frey - Lawyer in Philadelphia, PA

Since leaving the U.S. Attorneys Office in New Jersey, Jeremys representations have included internal investigations for public and privately held businesses, SEC investigations and enforcement proceedings, corporate compliance (including 1940 Investment Company Act compliance), health care compliance, public authorities, federal tax matters, commercial and real estate litigation, class action cases, qui tam proceedings, patent litigation, environmental compliance matters, whistle-blower employment cases, First Amendment litigation, forfeiture proceedings, and extensive representations of businesses and individuals in federal and state criminal investigations, cases and trials.

Jeremy has represented major health care companies, including pharmaceutical and medical device manufacturers, group purchasing organizations, pharmacy networks, health care supply and distribution-chain companies, hospitals, skilled nursing facilities, and long- term care facilities, as well as corporate executives, physicians, and public officials. He has extensive experience in regulatory issues impacting health care businesses, including federal and state fraud and abuse laws, AKS laws, Stark, the civil monetary penalties law, the false claims act and HIPAA, as well as billing, reimbursement, and claims issues. In addition to handling litigation and regulatory issues, Jeremy also has extensive experience assisting health care clients in their contractual relationships with business partners, health care industry commercial transactions, and in managing legal risks through compliance programs.

He also represents clients in matters involving the Anti-Kickback Statute, Foreign Corrupt Practices Act, Antiterrorism Act, Foreign Sovereign Immunities Act, the Alien Tort Claims Act, the gaming industry, and proceedings by U.S. Immigration and Customs Enforcement. He has handled numerous cases before the D.C. Circuit and the Second and Third Circuit Courts of Appeals.

Jeremys clients include national banks, group purchasing organizations, registered investment advisers, public agencies, broker-dealers, public companies, and businesses in the gaming industry, as well as corporate executives, public and labor union officials, and lobbyists.

Before joining the firm, Jeremy was the Assistant U.S. Attorney-in-Charge of the U.S. Attorneys Office in Camden, New Jersey. In more than 15 years as a prosecutor, Jeremy tried dozens of major cases and supervised hundreds of others. Before joining the Justice Department, Jeremy was in private practice, concentrating on corporate transactions, including secured lending, initial public offerings, mergers and acquisitions, and municipal bonds.

Jeremy has taught at Rutgers University School of Law. A former trustee of the Association of the Federal Bar of New Jersey, he is a former Chair of the Federal Criminal Law Committee, Eastern District of Pennsylvania, and is a member of its Executive Committee. Jeremy is a member of the Advisory Boards of BNAs Criminal Law Reporter and White Collar Crime Report. He is a non-governmental advisor to the International Competition Network (ICN). Jeremy is a co-author of H.R. 409 and S. 273, bills to divide New Jersey into two federal judicial districts, and H.R. 417, the Anti-Open Air Drug Market Act.

Jeremy has represented a national bank, major health care providers, group purchasing organizations, registered investment advisers, public agencies, broker-dealers, public companies and businesses in the gaming industry, as well as corporate executives, public and labor union officials and a lobbyist.

Before joining the firm, Jeremy was the Assistant U.S. Attorney-in-Charge of the U.S. Attorneys Office in Camden, New Jersey. In more than 15 years as a prosecutor, Mr. Frey tried dozens of major cases and supervised hundreds of others.

Jeremy has taught at Rutgers University School of Law. A former trustee of the Association of the Federal Bar of New Jersey, he is an officer of the Federal Bar Association, Criminal Law Committee, Philadelphia Chapter. He is a member of the Advisory Boards of BNAs Criminal Law Reporter and White Collar Crime Report. He is a non-governmental advisor to the International Competition Network (ICN), Cartel Working Group.